Ginkgo Bioworks Hldgs Inc (DNA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2008 | 03-2008 | 12-2007 | 09-2007 | 06-2007 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 1,764,000 | 983,000 | 2,769,000 | 2,138,000 | 1,453,000 |
| Depreciation Amortization | 285,000 | 139,000 | 492,000 | 345,000 | 215,000 |
| Income taxes - deferred | 217,000 | 75,000 | -234,000 | -116,000 | -103,000 |
| Accounts receivable | -59,000 | -11,000 | 38,000 | -236,000 | -115,000 |
| Other Working Capital | -1,230,000 | 8,000 | -77,000 | -448,000 | -238,000 |
| Other Operating Activity | 227,000 | -195,000 | 242,000 | 390,000 | 213,000 |
| Operating Cash Flow | $1,204,000 | $999,000 | $3,230,000 | $2,073,000 | $1,425,000 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -398,000 | -200,000 | -977,000 | -692,000 | -475,000 |
| Net Acquisitions | N/A | N/A | -833,000 | -833,000 | N/A |
| Purchase Of Investment | -953,000 | -654,000 | -1,152,000 | -622,000 | -465,000 |
| Sale Of Investment | 996,000 | 416,000 | 1,137,000 | 840,000 | 596,000 |
| Purchase Sale Intangibles | 24,000 | 22,000 | -40,000 | -39,000 | -8,000 |
| Other Investing Activity | 24,000 | 22,000 | -40,000 | -39,000 | -8,000 |
| Investing Cash Flow | $-331,000 | $-416,000 | $-1,865,000 | $-1,346,000 | $-352,000 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | N/A | N/A | 599,000 | N/A | N/A |
| Common Stock Issued | 228,000 | 147,000 | 452,000 | 381,000 | 276,000 |
| Common Stock Repurchased | -756,000 | N/A | -1,345,000 | -815,000 | -666,000 |
| Other Financing Activity | 32,000 | 39,000 | 193,000 | 160,000 | 127,000 |
| Financing Cash Flow | $-496,000 | $186,000 | $-101,000 | $-274,000 | $-263,000 |
| Beginning Cash Position | 2,514,000 | 2,514,000 | 1,250,000 | 1,250,000 | 1,250,000 |
| End Cash Position | 2,891,000 | 3,283,000 | 2,514,000 | 1,703,000 | 2,060,000 |
| Net Cash Flow | $377,000 | $769,000 | $1,264,000 | $453,000 | $810,000 |
| Free Cash Flow | |||||
| Operating Cash Flow | 1,204,000 | 999,000 | 3,230,000 | 2,073,000 | 1,425,000 |
| Capital Expenditure | -398,000 | -200,000 | -977,000 | -692,000 | -475,000 |
| Free Cash Flow | 806,000 | 799,000 | 2,253,000 | 1,381,000 | 950,000 |